Cited by 97Gut microbiota and healthAdipokines, Inflammation, and Metabolic DiseasesOral microbiology and periodontitis research

Gut microbiota in health and disease: an overview focused on metabolic inflammation

Nagpal, R., Kumar, M., Yadav, A.K., Hemalatha, R., Yadav, H., Marotta, F., Yamashiro, Y.·2016·Beneficial Microbes

Abstract

In concern to the continuously rising global prevalence of obesity, diabetes and associated diseases, novel preventive and therapeutic approaches are urgently required. However, to explore and develop such innovative strategies, a meticulous comprehension of the biological basis of these diseases is extremely important. Past decade has witnessed an enormous amount of research investigation and advancement in the field of obesity, diabetes and metabolic syndrome, with the gut microbiota receiving a special focus in the triangle of nutrition, health and diseases. In particular, the role of gut microbiota in health and diseases has been one of the most vigorous and intriguing field of recent research; however, much still remains to be elucidated about its precise role in host metabolism and immune functions and its implication in the onset, progression as well as in the amelioration of metabolic ailments. Recent investigations have suggested a significant contribution of the gut microbiota in the regulation and impairment of energy homeostasis, thereby causing metabolic disorders, such as metabolic endotoxemia, insulin resistance and type 2 diabetes. Numerous inflammatory biomarkers have been found to be associated with obesity, diabetes and risk of other associated adverse outcomes, thereby suggesting that a persistent low-grade inflammatory response is a potential risk factor. In this milieu, this review intends to discuss potential evidences supporting the disturbance of the gut microbiota balance and the intestinal barrier permeability as a potential triggering factor for systemic inflammation in the onset and progression of obesity, type 2 diabetes and metabolic syndrome.

Integrity signals

Registry

Crossref · 10.3920/bm2015.0062

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some studies have shown that probiotics, prebiotics, or a combination can reduce systemic inflammation and progression of central obesity, but more research is needed.

    “Some studies have shown that this strategy can reduce systemic inflammation and progression of central obesity, but more research in this area is needed to substantiate this initial evidence and to assess whether the reduction of inflammation owing to microbiota changes has beneficial effects on health84,85.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nagpal, R., Kumar, M., Yadav, A. K., Hemalatha, R., Yadav, H., Marotta, F., & Yamashiro, Y.
Affiliations
  • Juntendo University (JP)
  • National Institute of Nutrition (IN)
  • National Institutes of Health (US)
  • ReGenera Research Group for Aging Intervention, Via Moisé Loira 75, 20144 Milan, Italy
Venue
Beneficial Microbes
Published
2016-03-11
Volume
7
Issue
2
Pages
181-194
ISSN
  • 1876-2883 (ISSN-L)
  • 1876-2891
OpenAlex
W2196329954
Cited by
97
References
119
Citations by year
2026: 2 · 2025: 6 · 2024: 11 · 2023: 10 · 2022: 11 · 2021: 13 · 2020: 9 · 2019: 8 · 2018: 12 · 2017: 10 · 2016: 5
FWCI
0.87
Type
journal article
Language
en
Open access
closed
Locations
  • Beneficial Microbes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
gut microbiota, metabolic inflammation, obesity, type 2 diabetes, metabolic syndrome, energy homeostasis, insulin resistance, metabolic endotoxemia, intestinal permeability, low-grade inflammation, host metabolism, immune function
MeSH terms
Gastrointestinal Microbiome, Animals, Humans, Inflammation, Metabolic Diseases, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review